CD19 and acute lymphoblastic leukemia: Several groups have produced data regarding the efficacy of CD19-specific CB CAR-T cells, proving the cytolytic effect of CB-derived and -modified T cells both in vitro and in vivo in models of B-lineage acute lymphoblastic leukemia (B-ALL) (42, 51).